Dr. Benz has been part of a number of accomplishments at the institute. Under his tenure, fundraising at Dana-Farber grew to more than $200 million annually from a network of 300,000 donors, the number of patients seeking treatment at Dana-Farber tripled and revenues climbed from $265 million to more than $1 billion, according to the report.
Dr. Benz became the president and CEO of the cancer institute in 2000. Before assuming the presidency of the institute, he served as chairman of the Department of Medicine at the Johns Hopkins University School of Medicine and the Sir William Osler Professor of Medicine.
According to the report, Dr. Benz, a hematologist, plans to continue his research and his teaching role at Harvard Medical School after he retires.
More articles on executive moves:
Rare Genomics Institute announces new director and CEO
Edith Pemberton named CFO of East Morgan County Hospital
Scotland County Hospital names CMO
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
